| Line item | 2025-12-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $963.40M | $1.37B | $4.02B | $3.85B | $3.60B | $3.27B |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $89.70M | $101.80M | $490.50M | $531.10M | $475.40M | $486.60M |
| Operating Income | -$66.40M | -$170.40M | -$938.80M | -$1.86B | $9.00M | $170.60M |
| Interest Expense | – | – | $269.80M | $221.20M | $176.00M | $181.50M |
| Tax Expense | $300.00K | -$8.60M | -$65.00M | $21.30M | $28.40M | $17.10M |
| Net Income | -$108.50M | -$211.20M | -$1.10B | -$2.01B | -$188.20M | -$18.90M |
| EPS (basic) | -6.9200 | -12.6300 | -4.7700 | -8.8200 | -0.8400 | -0.0900 |
| EPS (diluted) | -6.9200 | -12.6300 | -4.7700 | -8.8200 | -0.8400 | -0.0900 |
| Shares (diluted) | $16.70M | $16.70M | $233.60M | $227.90M | $224.10M | $220.50M |